Compagnie Lombard Odier SCmA’s Quest Diagnostics DGX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-291	Closed	-$46K	–	634
2022 Q4	$46K	Buy	+291	New	+$41.8K	﹤0.01%	480
2018 Q1	–	Sell	-27	Closed	-$3K	–	613
2017 Q4	$3K	Buy	+27	New	+$2.56K	﹤0.01%	610
2016 Q1	–	Sell	-7,415	Closed	-$527K	–	983
2015 Q4	$527K	Hold	7,415	–	–	0.02%	310
2015 Q3	$456K	Buy	7,415 +115	+2%	+$8.04K	0.02%	286
2015 Q2	$531K	Buy	7,300 +6,212	+571%	+$459K	0.02%	298
2015 Q1	$84K	Hold	1,088	–	–	﹤0.01%	690
2014 Q4	$73K	Sell	1,088 -498	-31%	-$31.4K	﹤0.01%	591
2014 Q3	$96K	Sell	1,586 -634	-29%	-$39.1K	﹤0.01%	647
2014 Q2	$130K	Sell	2,220 -1,452	-40%	-$85K	0.01%	617
2014 Q1	$213K	Hold	3,672	–	–	0.01%	498
2013 Q4	$197K	Buy	+3,672	New	+$218K	0.01%	525

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Compagnie Lombard Odier SCmA's DGX Position: Q1 2023 in Review

Compagnie Lombard Odier SCmA sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 291 shares — an estimated $46K sold.

Compagnie Lombard Odier SCmA first reported a position in DGX in Q4 2013 and held it in 11 quarters. The position peaked at $531K in Q2 2015. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

Compagnie Lombard Odier SCmA reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 291 Quest Diagnostics shares in Q1 2023, an estimated $46K.
Compagnie Lombard Odier SCmA first reported a position in Quest Diagnostics in Q4 2013 and held it in 11 quarters.
Compagnie Lombard Odier SCmA's Quest Diagnostics position peaked at $531K in Q2 2015.
834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2023, filed 1 May 2023.